The hollows that develop around the eyes with age are not simply a skin problem. They trace back to a structural loss - four distinct fat compartments that quietly deflate over the decades, pulling the architecture of the periorbital region inward. No amount of skin removal corrects a compartment that has emptied. Periorbital fat grafting addresses the deficit directly, transferring fat from the patient's own body to rebuild what time has taken. This guide covers the full procedure in mechanical detail: how the fat is harvested and processed, why some of it survives and some does not, how surgeons place it safely in the most delicate skin on the face, and where filler is honestly the smarter choice.
What Periorbital Aging Does to the Fat Compartments
The eye socket is not a single chamber of fat. It contains four distinct age-sensitive compartments, each at a different anatomical depth, and each responsible for a specific region of the periorbital surface. Their loss is independent and progressive.
- Medial orbital fat pad - the first and most commonly depleted; its loss is the direct structural cause of the tear trough, the diagonal groove that runs from the inner corner of the eye toward the upper cheek.
- Central orbital fat pad - thinning here deepens and widens the hollow across the mid-lower lid, creating the tired sunken appearance that patients most commonly describe.
- Lateral orbital fat pad - deflation at the outer corner contributes to shadowing and a skeletonized look at the outer lower lid.
- Sub-orbicularis oculi fat (SOOF) - positioned just beneath the orbicularis muscle in the upper eyelid zone; SOOF atrophy drives upper sulcus hollowing, the deep-set appearance that makes the brow look heavy and the eye socket cavernous.
All four compartments sit at depths below the skin surface. Their volume is not supported by the overlying skin or the orbicularis muscle - it is intrinsic to the fat itself. This is the structural reason that blepharoplasty alone cannot correct volume loss. Excising skin tightens the surface but does nothing for an empty compartment underneath. In fact, older-style lower blepharoplasty that removed orbital fat rather than repositioning it accelerated hollowing in patients who already had volume deficit - a complication that drove the shift toward volume-preserving and volume-restoring approaches.
What Periorbital Fat Grafting Is, and Who Is a Candidate
Autologous fat grafting harvests living fat cells from the patient's own body - most often the abdomen, inner thighs, or flanks - processes them to remove non-viable material, and places them in precise micro-deposits within the periorbital compartments. Because the material is the patient's own tissue, there is no foreign implant and no allergic response to the graft itself.
A 2021 meta-analysis by Yang et al., published in PLoS ONE and covering 39 studies and more than 4,000 patients, found a patient satisfaction rate of 90.9% after autologous fat grafting to the periorbital area. Blinded assessors in the same analysis rated patients as looking an average of 5.4 years younger at three months. These figures reflect both the volumetric result and the skin-quality improvements the procedure produces over time through its stem cell content.
Candidates most likely to benefit share these characteristics:
- Visible hollow at the tear trough, upper sulcus, or both, driven by volume loss rather than skin laxity alone
- Skin quality too thin to safely receive hyaluronic acid filler - very thin lower eyelid skin risks showing filler as a bluish discoloration, a phenomenon called the Tyndall effect, that fat does not cause
- Sufficient donor fat - the periorbital region requires small volumes, so even lean patients typically qualify
- Stable weight, since significant fluctuation after surgery affects the survival and behavior of the transferred fat
- Readiness to wait three to six months for the final result, understanding that early swelling and deliberate overcorrection mask the outcome during recovery
Harvest: Where the Fat Comes From and How Cell Viability Is Preserved
The abdomen is the preferred donor site. It yields a high concentration of viable fat cells and is accessed through a small stab incision under tumescent local anesthesia, leaving no visible scar. The inner thighs and flanks are practical alternatives when the abdomen is unavailable or when minor contouring at the donor site is a secondary benefit.
Cell survival begins at harvest. The Coleman technique - the clinical standard since its detailed description in the 1980s - uses a blunt-tipped cannula connected to a syringe. The surgeon applies gentle, low negative pressure rather than powered suction, drawing fat into the cannula without shearing the adipocyte membranes. High-pressure powered harvest ruptures cells before they leave the donor site. The intact cell membrane is not a cosmetic detail; it is the structure that must survive for the cell to engraft, vascularize, and persist in the recipient site.
Purification: Centrifugation and the Three Types of Fat
Raw harvested fat is a mixture of viable adipocytes, blood, tumescent fluid, and oil released by cells that ruptured during harvest. All of it must be processed before injection; only the viable fat layer is used.
The Coleman technique uses centrifugation: syringes of harvested fat are spun at high speed for a brief cycle, separating the mixture into three layers. The bottom layer is aqueous fluid - blood and tumescent solution - drained off and discarded. The top layer is liquid oil from ruptured cells, blotted away. The middle layer is consolidated viable fat, pale yellow and ready for the next step.
From this centrifuged fat, surgeons prepare different products suited to different periorbital goals:
- Microfat - the centrifuged fat passed through a fine filter that reduces particle size while preserving intact adipocytes. This is the primary product for periorbital volumizing. Intact adipocytes can engraft, vascularize, and persist; controlled series have documented roughly 78% volume retention at six months with optimized technique. Microfat is placed in the upper sulcus, tear trough, and lateral orbital hollow to restore compartment volume.
- Nanofat - microfat mechanically emulsified further until every adipocyte is disrupted and particle size falls well below what microfat achieves. Nanofat contains no intact fat cells and provides zero lasting volume. Its value is its high concentration of adipose-derived stem cells (ADSCs) and the growth factors they secrete. Injected superficially into the thin lower eyelid skin, nanofat improves skin texture, reduces fine crepiness, and stimulates collagen - a skin-quality benefit that is entirely separate from volumizing.
- Macrofat - unfiltered centrifuged fat, appropriate only for large-volume augmentation in areas away from the eyelid. Too coarse for any periorbital application.
A single periorbital session commonly uses both microfat and nanofat, each placed at the appropriate depth and zone for its specific purpose.
Placing the Fat: Why Retrograde Micro-passes Succeed Where Bolus Injection Fails
The injection technique is where good outcomes separate from poor ones, and it is rarely explained in enough mechanical detail to make sense to patients. The critical concept is vascularization: every transplanted fat cell must establish contact with a blood supply within roughly 48 hours to survive. Cells that cannot reach oxygen through diffusion die and are resorbed, and a mass of dead fat liquefies into a firm nodule.
A bolus deposit - a single syringe push that places a large clump of fat in one location - creates exactly this problem. The surface cells of the clump touch viable tissue; the center cells are too far from any capillary to survive. The result is partial resorption that leaves visible firmness or irregular contour.
Retrograde micro-pass injection solves the problem geometrically. The surgeon inserts a blunt cannula to the target depth, then slowly withdraws it while gently expressing fat - depositing a thin ribbon of fat as the cannula retreats. Each pass creates a thread of fat in close contact with surrounding tissue, maximizing surface area and capillary proximity. Multiple passes at slightly different angles and depths build volume through layering. The fat survives because it is distributed in thin enough columns that every cell is near tissue that can feed it.
In the lower eyelid and tear trough, where the skin is among the thinnest on the face, the aliquot per pass must be very small. A single over-deposited pass in this zone produces a visible lump that is genuinely difficult to correct after healing. The sequence a surgeon follows:
- Mark the target hollow zones before any local anesthetic is infiltrated - fluid distorts tissue topography and makes accurate volume assessment unreliable.
- Harvest fat from the donor site through the small stab incision, using low-pressure blunt-cannula technique to protect cell viability.
- Process the fat by centrifugation; prepare microfat and nanofat fractions for the planned zones.
- Inject microfat into the deeper planes of the target compartments via multiple thin retrograde passes, building volume gradually and checking symmetry between sides throughout.
- Apply nanofat superficially into the lower eyelid dermis where skin-quality improvement is part of the plan.
- Assess contour symmetry under anesthesia and correct any visible irregularity before closing.
What Survives and Why: Engraftment Science and the Deliberate-Overfill Strategy
Published fat-graft survival rates across the medical literature span a wide range - from as low as 10% to as high as 90% - depending on harvest technique, processing method, recipient-site vascularity, and patient factors including smoking status and tissue perfusion. The low end of that range reflects poor technique: high-pressure harvest, inadequate processing, or bolus injection. The high end reflects optimized technique in well-vascularized patients.
The Yang et al. meta-analysis found a fat resorption rate of 19.6% at three months and 32.2% at twelve months after periorbital grafting. The clinical consequence is that resorption is predictable and continues through the first year after surgery. Surgeons account for it with deliberate overcorrection: they place more volume than the intended endpoint, calibrated to land at the target after expected resorption. This is not imprecision - it is the correct technical approach given the known biology.
Patients should understand what this means for recovery. Immediately after surgery, they look overfilled. Swelling and overcorrection are both present at once, making the early weeks impossible to interpret accurately. The result is not assessable until swelling resolves and the primary resorption phase is complete - typically around three months, with further minor settling through month twelve.
ADSCs within the fat drive the regenerative side of the result. They secrete growth factors that promote angiogenesis - the formation of new capillaries into the graft - and they can differentiate into new adipocytes to replace cells that die during engraftment and into endothelial cells that contribute to the new vasculature. Surviving fat grafts gradually become vascularized living tissue. This is a biologic benefit no synthetic filler replicates.
Combining Fat Grafting with Blepharoplasty in One Session
Periorbital fat grafting is frequently performed alongside upper or lower blepharoplasty, and the logic is direct: blepharoplasty addresses excess skin and muscle; fat grafting addresses the volume deficit that blepharoplasty cannot. Many patients have both problems simultaneously, and treating only one produces a result that looks incomplete.
The surgeon typically performs the blepharoplasty component first - removing or repositioning redundant tissue - then transitions to fat grafting once the skin-and-muscle work is done. The sequence matters because blepharoplasty changes the tissue planes and the apparent volume deficit. Grafting after the excision lets the surgeon assess actual residual hollowing rather than estimate it preoperatively.
A combined approach is specifically indicated when lower lid surgery would otherwise leave a patient with a hollow tear trough that blepharoplasty makes more apparent, or when upper blepharoplasty would deepen the sulcus by removing skin without restoring the SOOF volume that once filled the space above.
Fat Grafting vs. Dermal Fillers: An Honest Comparison
The standard summary - "fat lasts longer" - is accurate but incomplete. The more useful question is which option fits the specific deficit, anatomy, and patient priorities.
| Consideration | Periorbital fat grafting | Hyaluronic acid filler |
|---|---|---|
| Durability | Surviving fraction is long-lasting; touch-up may be needed after initial resorption | Typically requires retreatment within one to two years |
| Reversibility | Not reversible; overcorrection requires aspiration or revision | Fully reversible with hyaluronidase injection |
| Very thin lower eyelid skin | Safe - no Tyndall effect risk | Risk of bluish discoloration if placed too superficially |
| Volume of deficit | Better suited to moderate-to-large compartment loss | Better suited to mild, localized hollowing |
| Surgical context | Ideal when blepharoplasty is already planned | Preferred when no surgery is planned |
| Skin quality benefit | Yes - ADSCs improve texture and fine lines over months | Hydration only; no regenerative effect |
Hyaluronic acid filler earns its place when the deficit is mild, the patient wants to avoid a surgical procedure, reversibility matters, or the patient wants to test a degree of correction before committing. Fat grafting is the stronger choice when the deficit is substantial, the skin is too thin for safe filler placement, surgery is already planned, or permanence is the goal. Neither option is universally superior; the mismatch between the wrong technique and the specific patient anatomy generates poor outcomes on both sides of the comparison.
Complications: Contour Problems, Overcorrection, and the Vascular Risk Every Patient Should Understand
The Yang et al. meta-analysis reported an overall complication rate of 7.9% across more than 4,000 patients. The most common issues were edema, chemosis (conjunctival swelling), and contour irregularity. No severe systemic complications were common. The rate is context the nature of the complications matters as much as the number.
Contour irregularity is the most clinically significant common complication because it requires active management. The approach depends on timing:
- Irregularity within the first six to eight weeks frequently represents swelling combined with overcorrection and may resolve without intervention; no treatment is appropriate until swelling clears.
- Persistent firm nodules at three to six months can be softened with intralesional steroid injection, which reduces fibrous encapsulation around dead fat deposits without surgery.
- True overfilled compartments that persist after six months of healing can be partially corrected by careful aspiration through a fine cannula, though removing placed fat is technically less predictable than the original graft.
- Cases that do not respond to these measures may require open surgical revision.
The most serious risk associated with periorbital fat grafting - and with facial fat injection broadly - is vascular embolism. If fat enters an artery during injection, the embolus can travel retrogradely into the ophthalmic artery circulation and cause central retinal artery occlusion, resulting in permanent blindness. In rare cases the embolus reaches cerebral circulation and causes stroke. This risk is real and patients deserve a direct explanation of it before consenting.
The risk of vision loss after facial fat injection is most strongly associated with injections at the glabella and nose, which connect directly to the ophthalmic artery; periorbital injections carry lower but non-zero vascular risk.Aesthetic Plastic Surgery, 2022 systematic review
Surgeons reduce this risk through several technical measures: blunt cannulas push vessels aside rather than piercing them, unlike sharp needles; continuous cannula movement during injection prevents dwelling in one spot; small-increment injection at low pressure limits the volume of any accidental arterial deposit. These precautions substantially reduce vascular risk compared with needle technique, but they do not eliminate it. Ask your surgeon to walk through their specific vascular precautions during the consultation - this is a routine part of any informed consent discussion for this procedure.
Frequently Asked Questions
How long does the result from periorbital fat grafting last?
The fat that survives the initial engraftment period becomes vascularized living tissue and is long-lasting. The Yang et al. meta-analysis shows resorption continues through the first twelve months, after which the remaining volume stabilizes. Some patients schedule a second session after the year mark to refine volume, particularly in the tear trough where survival rates are variable.
Why does the result look overdone immediately after surgery?
Surgeons deliberately place more fat than the final target volume because a predictable fraction - roughly 20% within three months and about a third by twelve months - will be resorbed as the graft establishes its blood supply. The overcorrected early appearance is intentional, not an error. Final volume cannot be assessed accurately until at least three months post-procedure, once both swelling and the primary resorption phase have resolved.
Can periorbital fat grafting address the tear trough without any surgery?
Fat grafting is itself a surgical procedure requiring anesthesia and a recovery period - it is not a non-surgical treatment. For patients who want to address a tear trough hollow without undergoing surgery, hyaluronic acid filler placed by an experienced injector is the appropriate alternative. Fat grafting becomes the preferred option when the deficit is too large for filler to correct adequately, when the skin is too thin for safe filler placement, or when eyelid surgery is already planned.
What is the difference between microfat and nanofat, and does one work better for the eyes?
They serve different goals and are not interchangeable. Microfat contains intact adipocytes filtered to a small particle size; it provides durable compartment volume and is used in the tear trough, upper sulcus, and lateral orbital hollow. Nanofat is emulsified until no intact fat cells remain; it adds no volume but carries concentrated ADSCs that improve skin texture and fine lines when placed superficially in the lower eyelid skin. A single session often uses both, each placed at the correct depth for its purpose.
Is this procedure safe for patients who have had previous lower blepharoplasty?
Prior blepharoplasty - especially if orbital fat was excised - can leave the periorbital tissue more fibrotic and less well-vascularized, which may reduce fat-graft survival rates in the treated area. The procedure is still performed in post-blepharoplasty patients, but the surgeon must account for altered tissue planes and may plan for a touch-up session. Evaluation by a surgeon experienced in revision periorbital work is important before proceeding.
Does fat harvesting leave a noticeable scar at the donor site?
The harvest incision is a few millimeters long - just large enough to admit the cannula tip - and is closed with a single small suture or left to heal on its own. Under tumescent local anesthesia at the abdomen, inner thigh, or flank, the incision heals without a visible scar for the vast majority of patients. Mild bruising and tenderness at the donor site are expected for one to two weeks and resolve without treatment.
General information only, not medical advice. Individual anatomy and healing vary. See the disclaimer.